Innate Pharma S.A. (IPHA)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08	FY07	FY06	FY05
Revenue	51.90M	49.64M	12.11M	56.83M	68.97M	79.89M	32.63M	56.16M	17.91M	907.00K	12.47M	10.38M	11.74M	4.32M	7.72M	12.92M	14.29M	6.20M	1.30M
Cost of Revenue	56.02M	51.66M	47.00M	3.04M	45.16M	69.56M	67.00M	48.63M	29.91M	12.09M	7.58M	6.86M	1.64M	3.43M	3.35M	2.56M	2.77M	2.20M	944.00K
Gross Profit	-4.12M	-2.02M	-34.89M	53.79M	23.82M	10.34M	-34.37M	7.53M	-12.00M	-11.18M	4.89M	3.51M	10.10M	893.00K	4.37M	10.37M	11.52M	3.99M	356.00K
Operating Income	-12.67M	-11.65M	-47.83M	-13.69M	-27.05M	5.15M	-39.98M	7.57M	-10.77M	-19.97M	-2.79M	-3.39M	-7.57M	-13.69M	-15.54M	-11.01M	-9.09M	-7.24M	-6.42M
Interest Income	3.18M	4.78M	6.34M	4.86M	1.62M	1.58M	1.25M	-	27.00K	445.00K	244.00K	34.00K	945.00K	541.00K	-	1.19M	212.00K	1.20M	280.00K
Pretax Income	-7.57M	-57.97M	-45.48M	-63.98M	-20.76M	2.72M	-48.02M	12.94M	-6.71M	-19.65M	-2.89M	-3.20M	-6.98M	-13.66M	-14.63M	-9.85M	-8.92M	-6.04M	-6.13M
Net Income	-7.57M	-99.10M	-59.14M	-70.75M	-20.96M	3.05M	-48.38M	12.64M	-6.71M	-19.65M	-2.89M	-3.20M	-6.98M	-13.66M	-14.63M	-9.85M	-8.92M	-6.04M	-6.13M
Selling & General & Admin	11.75M	22.44M	25.52M	30.39M	49.58M	19.25M	16.18M	9.33M	5.88M	12.82M	10.67M	9.73M	9.79M	7.06M	10.06M	-	-	1.84M	1.08M
Research & Development	56.02M	51.66M	47.00M	58.61M	1.60M	69.56M	67.00M	48.63M	29.91M	22.67M	15.13M	13.42M	-	-	-	-	-	-	-
Other Expenses	-3.20M	-8.04M	-12.59M	-13.62M	-309.00K	-14.06M	-10.57M	-9.37M	-7.11M	-19.00K	179.00K	2.00K	7.88M	32.00K	909.00K	21.37M	20.61M	9.34M	5.69M
Operating Expenses	64.57M	66.06M	59.94M	75.38M	50.87M	74.75M	72.61M	48.59M	28.68M	8.76M	7.66M	6.88M	17.67M	14.58M	19.90M	21.37M	20.61M	11.18M	6.77M
Interest Expense	640.00K	5.32M	4.00M	6.76M	204.00K	102.00K	113.00K	124.00K	139.00K	-	-	225.00K	520.00K	509.00K	-	36.00K	39.00K	2.00K	-
Selling & Marketing Expenses	-	7.96M	9.53M	-861.00K	8.85M	1.11M	527.00K	450.00K	288.00K	314.00K	283.00K	406.00K	9.79M	7.06M	10.06M	-	-	207.00K	139.00K
Cost & Expenses	64.57M	66.06M	59.94M	75.38M	96.03M	74.75M	72.61M	48.59M	28.68M	20.85M	15.24M	13.75M	19.31M	18.01M	23.25M	23.93M	23.38M	13.38M	7.71M
Income Tax	-	41.13M	13.66M	6.76M	206.00K	-333.00K	368.00K	301.00K	139.00K	-24.00K	-51.00K	-146.00K	1.13M	-	46.00K	-	51.00K	1.20M	286.00K
Shares Outstanding (Basic)	80.45M	79.64M	79.54M	78.93M	66.91M	58.78M	54.35M	53.87M	51.58M	50.15M	38.70M	37.80M	37.69M	37.44M	26.30M	25.66M	25.08M	17.77M	14.90M
Shares Outstanding (Diluted)	80.45M	79.64M	79.54M	78.93M	66.91M	58.78M	54.35M	53.87M	53.40M	50.15M	38.70M	37.80M	37.69M	37.44M	26.30M	25.66M	25.08M	17.77M	14.90M
EPS (Basic)	-0.09	-1.24	-0.74	-0.9	-0.31	0.05	-0.89	0.23	-0.13	-0.39	-0.07	-0.08	-0.19	-0.36	-0.56	-0.38	-0.36	-0.34	-0.41
EPS (Diluted)	-0.09	-1.24	-0.74	-0.9	-0.31	0.05	-0.89	0.23	-0.13	-0.39	-0.07	-0.08	-0.19	-0.36	-0.56	-0.38	-0.36	-0.34	-0.41
EBITDA	-1.84M	-61.30M	-43.23M	43.10M	-20.86M	-3.30M	-35.65M	10.83M	-8.09M	-17.14M	-1.91M	-1.76M	-5.80M	-12.32M	-14.47M	-12.48M	-8.50M	-6.94M	-6.11M
Depreciation & Amortization	5.09M	4.42M	4.57M	9.38M	16.53M	7.40M	4.40M	3.26M	2.65M	2.34M	880.00K	839.00K	901.00K	1.10M	1.02M	539.00K	536.00K	298.00K	301.00K